S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
GH · Guardant Health, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$166.59
+4.07
(+2.50%)
● At close: October 21 at 4:00:00 PM EDT
$165.10
-1.56
(-0.94%)
Overnight:
8:12:43 PM EDT
DAY'S RANGE
$166.59
$162.00
$171.18
52-WEEK RANGE
$166.59
$65.96
$191.05
What's happening
- GH is up 2.50% today, trading at $166.59. — Live quote
- Volume today (148,473) is well below its 3-month average of 2,299,620. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (after market close), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.42 actual vs. $-0.42 estimated (-0.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 15
Buy 18
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (36 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
GH
+59.18%
vs S&P 500
+46.41%
1-YEAR RETURN
GH
+131.61%
vs S&P 500
+117.05%
6-MONTH RETURN
GH
+89.72%
3-MONTH RETURN
GH
+6.76%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.42
Est. $-0.42
MISS -0.0%
2026-04-26 (Q1 2026)
$-0.45
Est. $-0.51
BEAT +11.9%
2026-01-26 (Q4 2025)
$-1.00
Est. $-0.72
MISS -38.6%
2025-10-26 (Q3 2025)
$-0.74
Est. $-0.72
MISS -2.3%
Valuation Measures & Ratios
Enterprise Value4$22.84B
Forward P/E5—
PEG Ratio6-10.10
Price / Sales (TTM1)18.92
Price / Book735.72
EV4 / Revenue19.30
EV4 / EBITDA—
Profit Margin-38.33%
Operating Margin-40.24%
Return on Equity (ROE8)-246.60%
Return on Assets (ROA9)-25.48%
Avg Volume (3M)2,299,620
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $20.04B | $12.18B | $7.83B | $6.50B | $5.26B |
| P/E | -47.16 | -30.47 | -19.79 | -16.04 | -12.51 |
| Price/Sales | 17.67 | 12.15 | 8.77 | 8.09 | 7.10 |
| Price/Book | -89.90 | -67.29 | -22.08 | -21.29 | -20.97 |
| EV/Revenue | 18.07 | 12.67 | 9.37 | 8.69 | 7.67 |
| EV/EBITDA | -49.08 | -31.85 | -21.25 | — | — |
| ROE | 190.63% | 220.83% | 111.58% | 132.72% | 167.68% |
| ROA | -22.22% | -20.88% | -30.98% | -30.44% | -31.28% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short11,915,002
Change from Prior Settlement+8.14%
% of Float—
Days to Cover (Short Ratio)6.20
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 44.3% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +131.6%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -38.3%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-19; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on GH
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $335.0M | $301.7M | $265.2M | $232.1M | $203.5M | $191.5M | $177.2M | $168.5M |
| Operating income | -$129.1M | -$121.3M | -$99.0M | -$106.4M | -$111.0M | -$117.3M | -$100.6M | -$99.7M |
| Net income | -$120.1M | -$112.1M | -$92.7M | -$99.9M | -$95.2M | -$107.8M | -$102.6M | -$115.0M |
| EPS (diluted) | $-0.90 | $-0.85 | $-0.74 | $-0.80 | $-0.77 | $-0.88 | $-0.84 | $-0.94 |
| EPS (basic) | $-0.90 | $-0.85 | $-0.74 | $-0.80 | $-0.77 | $-0.88 | $-0.84 | $-0.94 |
| Operating margin | -$39 | -$40 | -$37 | -$46 | -$55 | -$61 | -$57 | -$59 |
| Net margin | -$36 | -$37 | -$35 | -$43 | -$47 | -$56 | -$58 | -$68 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.91B | $1.92B | $2.01B | $1.28B | $1.33B | $1.34B | $1.49B | $1.54B |
| Total liabilities | $2.14B | $2.10B | $2.11B | $1.63B | $1.64B | $1.60B | $1.63B | $1.60B |
| Stockholders' equity | -$222.9M | -$181.1M | -$99.3M | -$354.5M | -$305.5M | -$250.8M | -$139.6M | -$60.1M |
| Total current assets | $1.36B | $1.37B | $1.47B | $828.9M | $883.4M | $927.0M | $1.06B | $1.23B |
| Total current liabilities | $339.0M | $292.1M | $302.7M | $236.9M | $238.4M | $225.8M | $225.6M | $197.3M |
| Cash & equivalents | $1.05B | $989.3M | $378.2M | $580.0M | $629.1M | $698.6M | $525.5M | $585.0M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $144.2M | $137.4M | $137.8M | $115.6M | $130.3M | $115.4M | $110.3M | $88.5M |
| Inventory | $105.5M | $83.9M | $85.9M | $90.5M | $84.1M | $77.3M | $71.1M | $72.3M |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $155.3M | $150.0M | $145.9M | $124.6M | $126.1M | $129.3M | $136.8M | $125.2M |
| Goodwill | $77.3M | $77.3M | $77.3M | $3.3M | $3.3M | $3.3M | $3.3M | $3.3M |
| Intangible assets | $25.3M | $25.5M | $25.9M | $5.5M | $5.9M | $6.3M | $6.8M | $7.3M |
| Other non-current assets | $28.0M | $28.9M | $28.5M | $41.5M | $37.2M | $32.6M | $37.2M | $31.3M |
| Accounts payable | $93.5M | $75.0M | $54.4M | $20.1M | $44.8M | $49.8M | $38.6M | $15.5M |
| Accrued liabilities | $79.3M | $78.0M | $77.9M | $71.7M | $71.0M | $76.0M | $68.3M | $71.7M |
| Deferred revenue (current) | $44.8M | $47.8M | $50.8M | $46.9M | $54.4M | $36.3M | $35.5M | $29.6M |
| Long-term debt | $1.50B | $1.50B | $1.50B | $1.11B | $1.12B | $1.12B | $1.14B | — |
| Other non-current liabilities | $126.9M | $127.7M | $127.8M | $94.4M | $91.2M | $92.5M | $92.8M | $89.4M |
| Retained earnings | -$3.23B | -$3.11B | -$2.99B | -$2.87B | -$2.77B | -$2.67B | -$2.58B | -$2.47B |
| Accumulated other comprehensive income (loss) | -$5.6M | -$5.2M | -$4.9M | -$4.3M | -$3.7M | -$4.7M | -$5.2M | -$3.3M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$57.8M | -$65.6M | -$26.4M | -$35.4M | -$60.3M | -$62.7M | -$64.5M | -$51.1M |
| Investing cash flow | $101.5M | $699.4M | -$905.1M | -$14.3M | -$10.6M | $302.9M | $10.5M | -$294.8M |
| Financing cash flow | $23.0M | -$21.6M | $732.0M | $4.3M | $1.6M | -$66.8M | -$2.9M | -$2.9M |
| Free cash flow | -$69.5M | -$71.2M | -$54.2M | -$45.8M | -$65.9M | -$67.1M | -$83.4M | -$55.3M |
| Capital expenditures | $11.8M | $5.6M | $27.8M | $10.3M | $5.6M | $4.5M | $18.9M | $4.2M |
| Depreciation & amortization | $9.6M | $9.4M | $10.1M | $9.4M | $10.0M | $10.2M | $10.5M | $10.6M |
| Share-based compensation | $57.7M | $47.6M | $43.2M | $42.8M | $42.5M | $37.8M | $36.4M | $49.8M |
| Deferred income taxes | — | — | -$1.7M | — | — | — | $287.0K | — |
| Change in accounts receivable | $6.9M | -$942.0K | $22.2M | -$14.5M | $14.3M | $6.1M | $21.7M | -$12.1M |
| Change in inventory | $21.6M | -$2.0M | -$4.6M | $6.4M | $6.8M | $6.2M | -$1.2M | $5.3M |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Purchases of investments | $0 | $249.9M | $818.2M | $0 | $0 | $0 | $0 | $307.3M |
| Sales/maturities of investments | — | — | $0 | $0 | $0 | $307.3M | $0 | $0 |
| Other investing activities | — | — | — | — | — | — | — | — |
| Share repurchases | $0 | $0 | $0 | $0 | $0 | $45.0M | $0 | $0 |
| Tax withholding on stock comp | $8.3M | $20.6M | $5.4M | $2.3M | $7.4M | $15.5M | $8.0M | $2.9M |
| Other financing activities | $3.0M | -$4.5M | $765.0K | $2.9M | -$41.0K | -$3.0K | $59.0K | -$31.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $982.0M | $739.0M | $563.9M | $449.5M | $373.7M |
| Operating income | -$437.2M | -$443.6M | -$564.7M | -$544.4M | -$411.0M |
| Net income | -$416.3M | -$436.4M | -$479.4M | -$654.6M | -$384.8M |
| EPS (diluted) | $-3.32 | $-3.56 | $-4.28 | $-6.41 | $-4.00 |
| EPS (basic) | $-3.32 | $-3.56 | $-4.28 | $-6.41 | $-4.00 |
| Operating margin | -$45 | -$60 | -$100 | -$121 | -$110 |
| Net margin | -$42 | -$59 | -$85 | -$146 | -$103 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $2.01B | $1.49B | $1.79B | $1.61B | $2.20B |
| Total liabilities | $2.11B | $1.63B | $1.63B | $1.55B | $1.56B |
| Stockholders' equity | -$99.3M | -$139.6M | $158.7M | $60.2M | $645.0M |
| Total current assets | $1.47B | $1.06B | $1.35B | $1.19B | $1.11B |
| Total current liabilities | $302.7M | $225.6M | $205.9M | $193.2M | $194.7M |
| Cash & equivalents | $378.2M | $525.5M | $1.13B | $141.6M | $492.2M |
| Marketable securities (current) | — | — | — | $869.6M | $440.5M |
| Accounts receivable | $137.8M | $110.3M | $88.8M | $97.3M | $97.7M |
| Inventory | $85.9M | $71.1M | $61.9M | $51.6M | $30.7M |
| Marketable securities (non-current) | — | — | — | $0 | $698.0M |
| Property, plant & equipment | $145.9M | $136.8M | $145.1M | $167.9M | $124.5M |
| Goodwill | $77.3M | $3.3M | $3.3M | $3.3M | $3.3M |
| Intangible assets | $25.9M | $6.8M | $9.0M | $11.7M | $14.2M |
| Other non-current assets | $28.5M | $37.2M | $124.2M | $61.5M | $60.9M |
| Accounts payable | $54.4M | $38.6M | $51.7M | $68.9M | $38.5M |
| Accrued liabilities | $77.9M | $68.3M | $188.0M | $175.8M | $45.3M |
| Deferred revenue (current) | $50.8M | $35.5M | $18.0M | $17.4M | — |
| Long-term debt | $1.50B | $1.14B | — | — | — |
| Other non-current liabilities | $127.8M | $92.8M | $96.0M | $9.2M | $3.9M |
| Retained earnings | -$2.99B | -$2.58B | -$2.14B | -$1.66B | -$1.01B |
| Accumulated other comprehensive income (loss) | -$4.9M | -$5.2M | -$3.7M | -$19.5M | -$4.8M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$184.8M | -$239.9M | -$325.0M | -$309.5M | -$209.0M |
| Investing cash flow | -$627.2M | -$261.3M | $840.2M | $149.8M | -$63.2M |
| Financing cash flow | $671.1M | -$996.0K | $477.4M | -$189.1M | -$66.8M |
| Free cash flow | -$233.1M | -$274.9M | -$345.5M | -$386.9M | -$284.1M |
| Capital expenditures | $48.3M | $35.1M | $20.5M | $77.5M | $75.0M |
| Depreciation & amortization | $39.7M | $42.4M | $42.9M | $36.0M | $22.3M |
| Share-based compensation | $166.2M | $140.4M | $90.8M | $94.7M | $151.4M |
| Deferred income taxes | -$1.7M | $287.0K | -$541.0K | -$236.0K | $178.0K |
| Change in accounts receivable | $28.2M | $21.4M | -$8.4M | -$375.0K | $44.4M |
| Change in inventory | $14.8M | $9.1M | $10.3M | $20.9M | $8.0M |
| Change in accounts payable | — | — | — | — | $8.6M |
| Purchases of investments | $818.2M | $307.3M | $629.9M | $303.8M | $900.8M |
| Sales/maturities of investments | $307.3M | $35.0M | $1.49B | $555.0M | $952.1M |
| Other investing activities | — | — | -$1.5M | $0 | $0 |
| Share repurchases | $45.0M | $0 | $0 | — | — |
| Tax withholding on stock comp | $30.5M | $15.7M | $11.2M | $7.9M | $83.8M |
| Other financing activities | $3.6M | -$153.0K | $6.0M | -$1.1M | -$930.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding GH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers66.3%
Shares Outstanding132,867,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,622,935 | $1.14B | 5.74% | -34.0% | 2026-08-07 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6,514,952 | $977.4K | 4.90% | -7.2% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,755,857 | $863.6M | 4.33% | +2.3% | 2026-06-30 |
| FMR LLC | 5,488,272 | $823.4M | 4.13% | +33.3% | 2026-08-13 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,445,785 | $817.0M | 4.10% | -6.7% | 2026-06-30 |
| Invesco Ltd. | 4,429,755 | $664.6M | 3.33% | -10.4% | 2026-08-13 |
| Goldman Sachs Group Inc | 3,775,895 | $566.5M | 2.84% | -14.9% | 2026-08-14 |
| TWO SIGMA INVESTMENTS, LP | 3,719,301 | $558.0M | 2.80% | -12.1% | 2026-08-07 |
| Capital International Investors | 3,399,604 | $510.0M | 2.56% | -2.3% | 2026-08-07 |
| Deep Track Capital, LP | 3,393,312 | $509.1M | 2.55% | +1.6% | 2026-08-14 |
| Franklin Resources Inc | 3,236,065 | $485.5M | 2.44% | -6.2% | 2026-08-04 |
| Ameriprise Financial Inc | 3,150,897 | $472.8M | 2.37% | +122.7% | 2026-08-14 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,629,007 | $394.4M | 1.98% | +3.1% | 2026-08-12 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,521,596 | $378.4M | 1.90% | -28.1% | 2026-08-12 |
| BAILLIE GIFFORD & CO | 2,284,127 | $342.7M | 1.72% | -40.8% | 2026-08-06 |
| State Street Corp | 2,263,504 | $339.6M | 1.70% | -21.5% | 2026-08-07 |
| Federated Hermes, Inc. | 1,999,178 | $299.9M | 1.50% | +5.9% | 2026-08-12 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,957,828 | $293.8M | 1.47% | -17.1% | 2026-08-14 |
| LORD, ABBETT & CO. LLC | 1,813,491 | $272.1K | 1.36% | -4.5% | 2026-08-13 |
| JANE STREET GROUP, LLC | 1,783,444 | $267.6M | 1.34% | +37031.9% | 2026-08-14 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,624,459 | $243.7M | 1.22% | +19.2% | 2026-08-12 |
| MILLENNIUM MANAGEMENT LLC | 1,622,458 | $243.4M | 1.22% | +76.1% | 2026-08-14 |
| NORGES BANK | 1,548,518 | $232.3M | 1.17% | +0.0% | 2026-08-12 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,533,985 | $230.1M | 1.15% | +0.6% | 2026-08-14 |
| RTW INVESTMENTS, LP | 1,481,033 | $222.2M | 1.11% | +0.0% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-08-15 to 2026-10-17
Recent transactions
- Insiders have net sold 57,155 shares over the last 182 days, across 0 purchases and 14 sales.
- Most recent: Hidalgo Medina Manuel (Director) — Option exercise of 232 shares on 2026-10-17.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)57,155 sh(14 txns)
Net Shares-57,155
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Hidalgo Medina Manuel | Director | Option exercise | 2026-10-17 | 232 |
| Tariq Musa | Director | Open market sale | 2026-10-16 | 116 |
| Azar Alex M II | Director | Open market sale | 2026-10-14 | 69 |
| Saia John G. | Chief Legal Officer | Option exercise | 2026-10-01 | 974 |
| Monroe Terilyn J. | Chief People Officer | Option exercise | 2026-10-01 | 2,659 |
| Kalia Kumud | Chief Information Officer | Option exercise | 2026-10-01 | 1,607 |
| Freeman Chris | Chief Commercial Officer | Option exercise | 2026-10-01 | 1,929 |
| Chudova Darya | Chief Technology Officer | Option exercise | 2026-10-01 | 1,340 |
| Bell Michael Brian | Chief Financial Officer | Option exercise | 2026-10-01 | 2,085 |
| Talasaz AmirAli | Co-Chief Executive Officer | Option exercise | 2026-10-01 | 23,997 |
| Eltoukhy Helmy | Co-Chief Executive Officer | Option exercise | 2026-10-01 | 23,997 |
| MIGNONE ROBERTO | Director | Option exercise | 2026-09-21 | 264 |
| Krognes Steve E. | Director | Open market sale | 2026-09-16 | 1,103 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-17 | Hidalgo Medina Manuel | Director | Option exercise | 232 | $0.00 |
| 2026-10-16 | Tariq Musa | Director | Open market sale | 116 | $165.88 |
| 2026-10-15 | Tariq Musa | Director | Option exercise | 250 | $0.00 |
| 2026-10-14 | Azar Alex M II | Director | Open market sale | 69 | $159.89 |
| 2026-10-12 | Azar Alex M II | Director | Option exercise | 137 | $0.00 |
| 2026-10-01 | Saia John G. | Chief Legal Officer | Option exercise | 974 | $0.00 |
| 2026-10-01 | Saia John G. | Chief Legal Officer | Option exercise | 1,668 | $0.00 |
| 2026-10-01 | Saia John G. | Chief Legal Officer | Option exercise | 2,925 | $0.00 |
| 2026-10-01 | Saia John G. | Chief Legal Officer | Option exercise | 1,496 | $0.00 |
| 2026-10-01 | Saia John G. | Chief Legal Officer | Tax withholding | 3,706 | $174.75 |
| 2026-10-01 | Monroe Terilyn J. | Chief People Officer | Option exercise | 2,659 | $0.00 |
| 2026-10-01 | Monroe Terilyn J. | Chief People Officer | Option exercise | 1,360 | $0.00 |
| 2026-10-01 | Monroe Terilyn J. | Chief People Officer | Tax withholding | 2,098 | $174.75 |
| 2026-10-01 | Kalia Kumud | Chief Information Officer | Option exercise | 1,607 | $0.00 |
| 2026-10-01 | Kalia Kumud | Chief Information Officer | Option exercise | 1,084 | $0.00 |
| 2026-10-01 | Kalia Kumud | Chief Information Officer | Option exercise | 1,995 | $0.00 |
| 2026-10-01 | Kalia Kumud | Chief Information Officer | Option exercise | 1,360 | $0.00 |
| 2026-10-01 | Kalia Kumud | Chief Information Officer | Tax withholding | 3,067 | $174.75 |
| 2026-10-01 | Freeman Chris | Chief Commercial Officer | Option exercise | 1,929 | $0.00 |
| 2026-10-01 | Freeman Chris | Chief Commercial Officer | Option exercise | 1,668 | $0.00 |
| 2026-10-01 | Freeman Chris | Chief Commercial Officer | Option exercise | 2,527 | $0.00 |
| 2026-10-01 | Freeman Chris | Chief Commercial Officer | Option exercise | 1,292 | $0.00 |
| 2026-10-01 | Freeman Chris | Chief Commercial Officer | Tax withholding | 3,143 | $174.75 |
| 2026-10-01 | Chudova Darya | Chief Technology Officer | Option exercise | 1,340 | $0.00 |
| 2026-10-01 | Chudova Darya | Chief Technology Officer | Option exercise | 1,668 | $0.00 |
| 2026-10-01 | Chudova Darya | Chief Technology Officer | Option exercise | 3,324 | $0.00 |
| 2026-10-01 | Chudova Darya | Chief Technology Officer | Option exercise | 1,701 | $0.00 |
| 2026-10-01 | Chudova Darya | Chief Technology Officer | Tax withholding | 4,320 | $174.75 |
| 2026-10-01 | Bell Michael Brian | Chief Financial Officer | Option exercise | 2,085 | $0.00 |
| 2026-10-01 | Bell Michael Brian | Chief Financial Officer | Option exercise | 3,324 | $0.00 |
| 2026-10-01 | Bell Michael Brian | Chief Financial Officer | Option exercise | 1,871 | $0.00 |
| 2026-10-01 | Bell Michael Brian | Chief Financial Officer | Tax withholding | 3,914 | $174.75 |
| 2026-10-01 | Talasaz AmirAli | Co-Chief Executive Officer | Option exercise | 23,997 | $0.00 |
| 2026-10-01 | Talasaz AmirAli | Co-Chief Executive Officer | Option exercise | 9,716 | $0.00 |
| 2026-10-01 | Talasaz AmirAli | Co-Chief Executive Officer | Tax withholding | 17,087 | $174.75 |
| 2026-10-01 | Eltoukhy Helmy | Co-Chief Executive Officer | Option exercise | 23,997 | $0.00 |
| 2026-10-01 | Eltoukhy Helmy | Co-Chief Executive Officer | Option exercise | 9,716 | $0.00 |
| 2026-10-01 | Eltoukhy Helmy | Co-Chief Executive Officer | Tax withholding | 17,087 | $174.75 |
| 2026-09-30 | Talasaz AmirAli | Co-Chief Executive Officer | Option exercise | 2,817 | $0.00 |
| 2026-09-30 | Talasaz AmirAli | Co-Chief Executive Officer | Tax withholding | 1,428 | $178.36 |
| 2026-09-30 | Eltoukhy Helmy | Co-Chief Executive Officer | Option exercise | 2,817 | $0.00 |
| 2026-09-30 | Eltoukhy Helmy | Co-Chief Executive Officer | Tax withholding | 1,428 | $178.36 |
| 2026-09-21 | MIGNONE ROBERTO | Director | Option exercise | 264 | $0.00 |
| 2026-09-17 | Hidalgo Medina Manuel | Director | Option exercise | 232 | $0.00 |
| 2026-09-16 | Krognes Steve E. | Director | Open market sale | 1,103 | $174.46 |
| 2026-09-16 | Krognes Steve E. | Director | Open market sale | 3,300 | $175.42 |
| 2026-09-16 | Krognes Steve E. | Director | Open market sale | 1,300 | $176.34 |
| 2026-09-16 | Krognes Steve E. | Director | Open market sale | 971 | $177.48 |
| 2026-09-16 | Azar Alex M II | Director | Open market sale | 826 | $175.00 |
| 2026-09-16 | Tariq Musa | Director | Open market sale | 116 | $175.00 |
| 2026-09-15 | Chudova Darya | Chief Technology Officer | Open market sale | 7,738 | $178.00 |
| 2026-09-15 | Tariq Musa | Director | Option exercise | 249 | $0.00 |
| 2026-09-12 | Azar Alex M II | Director | Option exercise | 1,651 | $0.00 |
| 2026-09-11 | Kalia Kumud | Chief Information Officer | Open market sale | 4,000 | $158.05 |
| 2026-08-26 | Eltoukhy Helmy | Co-Chief Executive Officer | Other acquisition/disposition | 25,000 | $0.00 |
| 2026-08-26 | Eltoukhy Helmy | Co-Chief Executive Officer | Other acquisition/disposition | 25,000 | $0.00 |
| 2026-08-26 | Eltoukhy Helmy | Co-Chief Executive Officer | Gift | 30,000 | $0.00 |
| 2026-08-21 | Talasaz AmirAli | Co-Chief Executive Officer | Open market sale | 9,023 | $168.20 |
| 2026-08-21 | Talasaz AmirAli | Co-Chief Executive Officer | Open market sale | 20,888 | $169.16 |
| 2026-08-21 | Talasaz AmirAli | Co-Chief Executive Officer | Open market sale | 7,589 | $170.29 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 03:35 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-19 | 4 | 2026-10-17 | View on SEC.gov → |
| 2026-10-19 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-15 | 4 | 2026-10-14 | View on SEC.gov → |
| 2026-10-13 | 4 | 2026-10-12 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
Recent news
Headlines about GH (Guardant Health, Inc.). Links open the publisher — we don’t host full articles.
-
GH The Rinse: Lucy’s Scheming Ways Backfire in More Ways Than One
Soap Hub · 2026-10-21 -
ETI drags GSE Composite Index lower for second straight session
News Ghana · 2026-10-21 -
Natera Partners With TransCode to Advance Colorectal Cancer Trial
Yahoo · 2026-10-21 -
GH Dec 2026 150.000 put (GH261218P00150000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-21 -
Guardant Health, Inc. (GH) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
Guardant Health, Inc. (GH) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
'GH' Star Laura Wright Shares Family Update That Has Her 'Thrilled'
TV Insider · 2026-10-20 -
GH Jan 2027 135.000 put (GH270115P00135000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-20
No headlines in this category right now — try “All”.